Abstract
Paragangliomas are catecholamine-secreting tumors external to the adrenal glands, most commonly arising in the head and neck, followed by the abdominal and thoracic cavities. The heart is a rare location for paragangliomas to originate from, with fewer than 50 cases as described in the literature. Functional paragangliomas of the right atrium are even more unusual, with only five cases reported to date. The investigations and therapies of a 41-year-old male presenting with a clinically functional cardiac paraganglioma are discussed. We performed a detailed pathology review of the primary cardiac tumor and a lung nodule to examine morphologic changes, along with an immunohistochemical profile (chromogranin A, tyrosine hydroxylase, MIB-1, and succinate dehydrogenase subunit B (SDHB)) of both tumors. Genetic testing of germline mutations in SDH genes was also completed. Both the 9.5-cm cardiac mass and 0.5-cm lung nodule were positive for chromogranin A and tyrosine hydroxylase and showed a global loss of SDHB expression. The MIB-1 labeling index of the smaller lesion and the bulk of the larger lesion was <5 %, but there were cellular foci of the larger lesion that had a labeling index of 10%. Genetic testing yielded an intronic frameshift mutation in the SDHC gene, c.IVS 5 + 1, G > A. We report the first case of a functional cardiac paraganglioma associated with an intronic frameshift SDHC gene mutation.
This is a preview of subscription content, log in via an institution to check access.
References
McNichol, A.M., Young, W.F., Kawashima, A., Komminoth, P., Tischler, A.S. (2004) Benign pheochromocytoma. (R.A.L.R. DeLellis, P.U. Heitz, C. Eng, eds.), pp. 151–155. Lyon, France, IARC Press, pp. 151–155.
Bravo, E.L., Gifford, R.W.,Jr (1984) Current concepts. Pheochromocytoma: diagnosis, localization and management. N.Engl.J.Med. 311:1298–1303.
Neumann, H.P., Eng, C. (2009) The approach to the patient with paraganglioma. J.Clin.Endocrinol.Metab. 94:2677–2683.
Vicha, A., Musil, Z., Pacak, K. (2013) Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options. Curr Opin Endocrinol Diabetes Obes. 20:186–191.
Eisenhofer, G., Tischler, A.S., de Krijger, R.R. (2011) Diagnostic Tests and Biomarkers for Pheochromocytoma and Extra-adrenal Paraganglioma: From Routine Laboratory Methods to Disease Stratification. Endocr Pathol.
Erickson, D., Kudva, Y.C., Ebersold, M.J., Thompson, G.B., Grant, C.S., van Heerden, J.A., et al. (2001) Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J.Clin.Endocrinol.Metab. 86:5210–5216.
Elsayes, K.M., Narra, V.R., Leyendecker, J.R., Francis, I.R., Lewis, J.S.,Jr, Brown, J.J. (2005) MRI of adrenal and extraadrenal pheochromocytoma. AJR Am.J.Roentgenol. 184:860–867.
van Nederveen, F.H., Gaal, J., Favier, J., Korpershoek, E., Oldenburg, R.A., de Bruyn, E.M., et al. (2009) An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol. 10:764–771.
Pasini, B., McWhinney, S.R., Bei, T., Matyakhina, L., Stergiopoulos, S., Muchow, M., et al. (2008) Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur.J.Hum.Genet. 16:79–88.
Mandak, J.S., Benoit, C.H., Starkey, R.H., Nassef, L.A.,Jr (1996) Echocardiography in the evaluation of cardiac pheochromocytoma. Am.Heart J. 132:1063–1066.
Kennelly, R., Aziz, R., Toner, M., Young, V. (2008) Right atrial paraganglioma: an unusual primary cardiac tumour. Eur.J.Cardiothorac.Surg. 33:1150–1152.
Kudva, Y.C., Young, W.F., Thompson, G.B., Grant, C.S., van Heerden, J.A. (1999) Adrenal incidentaloma: an important component of the clinical presentation spectrum of benign sporadic adrenal pheochromocytoma. Endocrinologist 9:77–80.
Timmers, H.J., Chen, C.C., Carrasquillo, J.A., Whatley, M., Ling, A., Havekes, B., et al. (2009) Comparison of 18 F-fluoro-L-DOPA, 18 F-fluoro-deoxyglucose, and 18 F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J.Clin.Endocrinol.Metab. 94:4757–4767.
Brink, I., Hoegerle, S., Klisch, J., Bley, T.A. (2005) Imaging of pheochromocytoma and paraganglioma. Fam.Cancer. 4:61–68.
Nguyen, H.H., Proye, C.A., Carnaille, B., Combemale, F., Pattou, F.N., Huglo, D. (1999) Tumour size: the only predictive factor for 131I MIBG uptake in phaeochromocytoma and paraganglioma. Aust.N.Z.J.Surg. 69:350–353.
Amar, L., Bertherat, J., Baudin, E., Ajzenberg, C., Bressac-de Paillerets, B., Chabre, O., et al. (2005) Genetic testing in pheochromocytoma or functional paraganglioma. J.Clin.Oncol. 23:8812–8818.
Schiavi, F., Boedeker, C.C., Bausch, B., Peczkowska, M., Gomez, C.F., Strassburg, T., et al. (2005) Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA 294:2057–2063.
Ricketts, C., Woodward, E.R., Killick, P., Morris, M.R., Astuti, D., Latif, F., et al. (2008) Germline SDHB mutations and familial renal cell carcinoma. J.Natl.Cancer Inst. 100:1260–1262.
Burnichon, N., Rohmer, V., Amar, L., Herman, P., Leboulleux, S., Darrouzet, V., et al. (2009) The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J.Clin.Endocrinol.Metab. 94:2817–2827.
Acknowledgments
The authors thank Dr. Hanna Faghfoury and Melanie Care from the Fred A. Litwin Family Centre in Genetic Medicine at the University Health Network and Mount Sinai Hospital in Toronto for their assistance in patient genetic counseling.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Millar, A.C., Mete, O., Cusimano, R.J. et al. Functional Cardiac Paraganglioma Associated with a Rare SDHC Mutation. Endocr Pathol 25, 315–320 (2014). https://doi.org/10.1007/s12022-013-9296-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12022-013-9296-1